Case report reveals distinct genital development in twins with a PPP1R12A mutation, suggesting implications for DSD management.
Loss-of-function variants in protein phosphatase 1 regulatory subunit 12A (PPP1R12A) can lead to urogenital and/or brain malformation syndrome (UBMS). When UBMS individuals exhibit genital abnormalities, it is combined with disorders of sex development (DSD). To report a PPP1R12A de novo variation in a case of 46,XY twins exhibiting different phenotypes of genital development. Twin A exhibited more feminine external genitalia (Prader III), while Twin B showed severe hypospadias (Prader IV) along with left cryptorchidism and right hernia. Endocrine evaluation and ultrasonography revealed that Twin A had bilateral gonadal dysgenesis, confirmed by gonadal pathology, while Twin B had well-functioning testes. Both twins were identical with a 46,XY karyotype. Genetic sequencing identified a novel heterozygous de novo mutation (c.1551-2A>G) in the PPP1R12A gene. Following a discussion with the multidisciplinary team (MDT) and the parents, Twin A was assigned female and underwent feminization surgery, while Twin B continued to be raised as male and received hypospadias repair. The Pre-School Activities Inventory scale was applied to assess their psychosexual development at 3.5 years old: Twin A scored 55.95 (neutral, slightly inclined to male), while Twin B scored 84.55 (male). This is the first instance of identical twins with a heterozygous mutation (c.1551-2A>G) in the PPP1R12A gene, associated with UBMS and DSD. The same variation resulted in identical twins exhibiting different genital phenotypes and choosing to live as different genders.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: